Barely Significant
← all excerpts

Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population.

Vaccines (Basel) · 2021 · PMC8703694 · PMID 34960122

Europe PMCDOI
1
hedged sentence
0.0616
closest p · 1.2× alpha
0.0616
boldest claim

The sentences

approaching significancep = 0.0616so close (0.05 < p ≤ 0.1)
The standard dose boosted group remained superior in enhancing IgG responses compared to the half dose group (median = 2622 and 1952 BAU/mL, respectively), but the difference was approaching significance ( p = 0.0616) ( Figure 4 A).

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.